Breaking News Bar

Business News and Information

Johnson & Johnson to supply up to 400M doses of potential COVID-19 vaccine to EU

Johnson & Johnson will supply the European Union with up to 400 million doses of its COVID-19 vaccine candidate following approval from regulators, the pharmaceutical giant announced Thursday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear